Interim Report Fourth Quarter 2022 January 1 – December 31 2022 Kancera AB (publ.), org.nr. 556806-8851
Year in briefOctober – DecemberFinancial summary for the fourth quarter Net sales amounted to SEK 0 million (SEK 0.0 million). R&D costs amounted to SEK 11,6 million (12,9 million). Operating profit for the fourth quarter amounted to SEK -14,0...
Read More